EKSO Insider Trading
EKSO BIONICS HOLDINGS, INC. | General Industrial Machinery & Equipment, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at EKSO BIONICS HOLDINGS, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the General Industrial Machinery & Equipment, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-21 00:57 | 2026-02-19 | ASHER DANIEL | 10% owner | BUY | $12.30 | 15,540 | $191,162 | 270,432 | +6.1% |
| 2026-02-20 00:03 | 2026-02-19 | ASHER DANIEL | 10% owner | BUY | $9.60 | 1,200 | $11,520 | 259,992 | +0.5% |
| 2026-02-17 23:42 | 2026-02-06 | ASHER DANIEL | 10% owner | BUY | $9.51 | 102,029 | $970,071 | 258,792 | +65.1% |
| 2026-01-08 00:45 | 2026-01-06 | Jones Jason C | Officer - Chief Operating Officer | SELL | $9.25 | 1,320 | $12,210 | 25,621 | -4.9% |
| 2025-12-11 00:05 | 2025-12-09 | Jones Jason C | Officer - Chief Operating Officer | SELL | $4.70 | 270 | $1,269 | 26,941 | -1.0% |
| 2025-12-11 00:05 | 2025-12-09 | Wong Jerome | Officer - Chief Financial Officer | SELL | $4.70 | 1,238 | $5,819 | 24,771 | -4.8% |
| 2025-11-13 01:05 | 2025-11-10 | Wong Jerome | Officer - Chief Financial Officer | SELL | $4.80 | 11,288 | $54,182 | 26,009 | -30.3% |
| 2025-11-13 01:05 | 2025-11-10 | Jones Jason C | Officer - Chief Operating Officer | SELL | $4.80 | 9,723 | $46,670 | 27,211 | -26.3% |
| 2025-11-13 01:04 | 2025-11-10 | Davis Scott G. | Director, Officer - CEO | SELL | $4.80 | 23,315 | $111,912 | 78,777 | -22.8% |
| 2024-03-15 01:41 | 2023-08-10 | Lathan Corinna | Director | BUY | $1.13 | 13,733 | $15,477 | 147,990 | +10.2% |
| 2023-08-19 04:44 | 2023-08-17 | Davis Scott G. | Officer - President & COO | SELL | $1.00 | 37,446 | $37,281 | 331,372 | -10.2% |
| 2023-08-19 04:40 | 2023-08-17 | Wong Jerome | Officer - Chief Financial Officer | SELL | $1.00 | 12,784 | $12,728 | 266,953 | -4.6% |
| 2023-05-27 01:45 | 2023-05-24 | SHERMAN STEVEN | Officer - Executive Chair | SELL | $1.44 | 45,660 | $65,874 | 364,913 | -11.1% |
| 2023-05-18 02:42 | 2023-05-08 | Jones Jason C | Officer - Chief Operating Officer | SELL | $1.57 | 3,435 | $5,401 | 138,554 | -2.4% |
| 2022-12-08 05:09 | 2022-12-04 | SHERMAN STEVEN | Director, Officer - Executive Chair | OPT+S | $1.28 | 10,576 | $13,492 | 728,664 | 0.0% |
| 2022-11-23 23:17 | 2022-11-21 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | OPT+S | $1.26 | 5,787 | $7,312 | 708,042 | 0.0% |
| 2022-11-18 01:49 | 2022-11-16 | Jones Jason C | Officer - Senior VP Product Development | SELL | $1.28 | 782 | $1,003 | 124,982 | -0.6% |
| 2022-11-18 01:47 | 2022-11-16 | Wong Jerome | Officer - Chief Financial Officer | SELL | $1.28 | 723 | $927 | 101,469 | -0.7% |
| 2022-10-27 01:31 | 2022-10-24 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | OPT+S | $1.29 | 5,921 | $7,619 | 698,230 | 0.0% |
| 2022-09-27 02:20 | 2022-09-22 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | OPT+S | $1.75 | 6,043 | $10,553 | 688,551 | 0.0% |
| 2022-09-03 00:50 | 2022-08-31 | Jones Jason C | Officer - Senior VP Product Development | SELL | $2.31 | 5,873 | $13,587 | 125,764 | -4.5% |
| 2022-08-23 22:09 | 2022-08-22 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | OPT+S | $2.20 | 5,572 | $12,278 | 678,995 | 0.0% |
| 2022-08-05 02:56 | 2022-08-03 | Wong Jerome | Officer - InterimChief Financial Officer | SELL | $1.80 | 1,675 | $3,021 | 102,192 | -1.6% |
| 2022-07-26 03:27 | 2022-07-25 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | OPT+S | $1.75 | 5,662 | $9,909 | 668,968 | 0.0% |
| 2022-07-20 23:01 | 2022-07-18 | Wong Jerome | Officer - InterimChief Financial Officer | SELL | $1.71 | 98 | $167 | 103,867 | -0.1% |
| 2022-07-06 04:39 | 2022-06-30 | Davis Scott G. | Officer - President & COO | SELL | $1.72 | 4,997 | $8,595 | 368,818 | -1.3% |
| 2022-06-23 03:14 | 2022-06-22 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | OPT+S | $1.74 | 5,330 | $9,259 | 659,031 | 0.0% |
| 2022-06-18 03:22 | 2022-06-15 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | SELL | $1.90 | 6,911 | $13,118 | 648,762 | -1.1% |
| 2022-05-27 03:32 | 2022-05-24 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | SELL | $1.76 | 6,597 | $11,605 | 637,408 | -1.0% |
| 2022-05-03 00:28 | 2022-04-28 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | SELL | $2.41 | 6,862 | $16,521 | 628,406 | -1.1% |
| 2022-04-27 00:13 | 2022-04-20 | Davis Scott G. | Officer - President & COO | SELL | $2.62 | 4,043 | $10,583 | 73,815 | -5.2% |
| 2022-03-28 23:52 | 2022-03-22 | GLENN JOHN | Officer - Chief Financial Officer | SELL | $2.82 | 3,462 | $9,762 | 35,130 | -9.0% |
| 2022-03-28 23:44 | 2022-03-22 | Jones Jason C | Officer - VP of Product Development | SELL | $2.82 | 3,265 | $9,206 | 81,637 | -3.8% |
| 2022-03-26 03:53 | 2022-03-24 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | SELL | $2.94 | 6,389 | $18,784 | 619,669 | -1.0% |
| 2022-03-18 00:19 | 2022-03-15 | SHERMAN STEVEN | Director, Officer - CEO & Chairman | SELL | $2.60 | 5,965 | $15,508 | 610,459 | -1.0% |
| 2019-06-19 20:56 | 2019-05-31 | Peurach Jack | Director, Officer - Chief Executive Officer | SELL | $1.37 | 31,437 | $43,069 | 78,120 | -28.7% |
| 2019-06-19 20:53 | 2019-05-31 | Jones Jason C | Officer - VP of Product Development | SELL | $1.31 | 9,430 | $12,353 | 3,070 | -75.4% |
| 2019-06-19 20:48 | 2019-05-31 | GLENN JOHN | Officer - Chief Financial Officer | SELL | $1.37 | 10,292 | $14,100 | 4,708 | -68.6% |
| 2018-05-26 00:07 | 2018-05-23 | SHERMAN STEVEN | Director | BUY | $1.51 | 200,000 | $301,560 | 400,825 | +99.6% |
| 2017-11-28 00:12 | 2017-11-22 | Angold Russ | Officer - President, EksoWorks | SELL | $3.51 | 50,000 | $175,500 | 391,326 | -11.3% |
| 2017-09-19 01:47 | 2017-09-14 | Peurach Jack | Director | BUY | $1.27 | 20,000 | $25,400 | 48,224 | +70.9% |
| 2017-09-16 00:05 | 2017-09-14 | Wendell Amy McBride | Director | BUY | $1.23 | 16,264 | $20,005 | 16,264 | +100.0% |
| 2017-09-13 01:47 | 2017-09-08 | Looby Thomas | Director, Officer - President & CEO | BUY | $1.13 | 15,000 | $16,950 | 20,315 | +282.2% |
| 2017-09-08 20:26 | 2017-09-07 | SCHEDER-BIESCHIN MAX | Officer - Chief Financial Officer | BUY | $1.13 | 10,000 | $11,300 | 32,371 | +44.7% |
| 2017-08-26 01:09 | 2017-08-23 | Angold Russ | Officer - President, EksoWorks | SELL | $1.33 | 9,352 | $12,438 | 241,326 | -3.7% |
| 2017-08-19 00:00 | 2017-08-16 | Angold Russ | Officer - President, EksoWorks | SELL | $1.53 | 28,254 | $43,229 | 250,678 | -10.1% |
| 2017-08-16 01:37 | 2017-08-11 | Angold Russ | Officer - President, Ekso Labs | SELL | $1.55 | 221,746 | $343,573 | 278,932 | -44.3% |
| 2016-11-15 22:36 | 2016-11-11 | SCHEDER-BIESCHIN MAX | Officer - Chief Financial Officer | BUY | $4.00 | 1,000 | $3,995 | 9,817 | +11.3% |
| 2016-11-15 22:06 | 2016-11-11 | Looby Tom | Director, Officer - President & CEO | BUY | $3.98 | 1,000 | $3,983 | 1,600 | +166.7% |
How to Interpret $EKSO Trades
Not every insider transaction in EKSO BIONICS HOLDINGS, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $EKSO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for EKSO
Insider activity data for EKSO BIONICS HOLDINGS, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $EKSO, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.